Efficacy of roflumilast in the treatment of psoriasis – a randomised controlled trial
Latest Information Update: 30 Jun 2023
At a glance
- Drugs Roflumilast (Primary) ; Roflumilast (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Acronyms The PSORRO trial
- 27 Jun 2023 Status changed from active, no longer recruiting to completed.
- 07 Jul 2022 Planned End Date changed from 1 Apr 2022 to 1 Apr 2025.
- 07 Jul 2022 Planned primary completion date changed from 1 Dec 2021 to 31 Aug 2022.